NAVKIDS2:结局指标与干预匹配的教训
NAVKIDS2 试验在 162 名来自边缘人群的慢性肾脏病患儿中评估患者导航项目。干预未使自报健康出现定量变化,但定性资料显示在减轻照护者负担和促进照护协调方面有实质获益。未来研究应识别能捕捉患者在照护协调、赋权和自我管理中所体验获益的定量指标。
要点
- 患者导航干预未改变慢病患儿自报健康的定量结局。
- 定性资料提示导航可减轻照护者负担并促进照护协调。
- 后续研究需开发能捕捉照护协调与赋权获益的定量指标。
核心结论
- 患者导航项目未改善慢病患儿自报健康的定量指标,但定性数据显示照护者负担减轻与照护协调改善。
研究设计与样本
- NAVKIDS2 试验纳入 162 名来自边缘人群的慢性肾脏病患儿,评估患者导航项目。
主要发现
- 干预与自报健康的定量变化无关联。
- 定性资料表明干预在减轻照护者负担和促进照护协调方面有实质获益。
临床怎么用
- 评估患者导航类干预时,除定量健康结局外应关注照护者负担与照护协调等定性获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patient navigator programs may improve outcomes among individuals with chronic kidney disease by reducing barriers to evidence-based care. The NAVKIDS2 trial evaluated a patient navigation program among 162 children with chronic kidney disease from marginalized populations. The intervention was not associated with quantitative changes in self-reported health, but qualitative data indicated substantial benefit in alleviating caregiver strain and facilitating care coordination. Future studies should identify quantitative measures that capture the benefits experienced by patients in care coordination, empowerment, and self-management.
引用
- Willard-Grace R, Tuot DS. NAVKIDS2: a lesson in matching outcome measures to interventions. Kidney Int. 2024. PMID: 39304272. doi:10.1016/j.kint.2024.07.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。